Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac

EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B:14,P1.7,16

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00450554

Enrollment

236

Registered

2007-03-22

Start date

2007-02-28

Completion date

2008-05-31

Last updated

2012-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination

Keywords

Neisseria meningitidis B:14, P1-7, 16, Serum bactericidal activity, Menbvac

Brief summary

The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (\>= 4), before and after the third MenBvac vaccination.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Years to 7 Years

Healthy volunteers

Yes

Inclusion criteria

* children born between 01/01/2000 and 06/23/2005, living in Dieppe-Est, Dieppe-Ouest and Offranville, vaccinated twice by MenBVac * parental authority(ies)assent

Exclusion criteria

* no parental authority(ies)assent * no blood sample during the third vaccination * impossibility of third vaccination

Countries

France

Outcome results